We came across a bullish thesis on Veeva Systems Inc. on LongTermValue Research’s Substack. In this article, we will ...

In its upcoming report, Veeva Systems (VEEV) is predicted by Wall Street analysts to post quarterly earnings of $1.95 per share, reflecting an increase of 11.4% compared to the same period last year.

If you are wondering whether Veeva Systems at around US$209.98 is a fair price, a premium, or an opportunity, this article is ...

Amazon Web Services, an Amazon.com company, and Veeva Systems, a provider of software, data and business consulting for the life sciences industry, announced an expansion of their collaboration. Veeva ...

Veeva Systems is executing well its migration plan from Salesforce to Veeva Vault CRM, positioning itself for double-digit revenue growth. Better than expected Q2 2023 results with revenue of $590.2 ...

Veeva Systems focuses on providing cloud software and applications for the life sciences industry, including pharmaceuticals and biotech companies, making it unique in the market. Key growth drivers ...

Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...

Veeva Systems, based in Pleasanton, Calif., is chiefly involved in providing cloud computing services for the life sciences and pharmaceutical industries. Veeva Systems Veeva Systems is chiefly ...

Veeva Systems VEEV is entering a pivotal phase as it gradually transitions away from Salesforce’s infrastructure, aiming to complete the shift by the end of September 2025. This move marks a ...

Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the ...

Veeva previously faced restrictions on integrating IQVIA’s industry-leading data into its commercial products, such as Veeva Network and Nitro, which limited competitiveness. The company has now ...

Veeva's business model is operationally leveraged, and the company gets more profitable with every sale. Its services save pharma and biotech customers massive amounts of time and money. The stock is ...